COVID-19 has had, and will continue to have, significant emotional, mental health, and social impacts on society.  Psilocybin, when administer in a clinical setting, is a breakthrough therapeutic component to conquering anxiety, depression, alcoholism, and other devastating mental health issues.  Oregon passed legislation in 2020 and Colorado in 2022 for the administration of Psilocybin in clinical settings, and more states are soon to follow including Washington State if passage of Senate Bill 5263 is successful.